GCLM and diabetes mellitus: We observed that, along with the reduced Nrf2 activation in diabetes, there was also a decrease in the content of GSH and protein expression of xCT, GCLM, and GPX4 (seen as a decrease in overall tissue immunopositivity and protein content).